Fundz

Fundz Deep Dive

Everything you need to win Biodimension — in one platform.

Who to reach, what to say, and why now on Biodimension — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Biodimension — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Biodimension secures Rs 8 Cr from IAN Angel Fund and others. The funds will accelerate product development and support commercialization efforts.

PRIVATEJun 11, 2026•4 days ago

Amount Raised

₹80 Million

Round Type

seed

BengaluruBiotechnologyLife Science

Investors

Aaryan BaidDr. Sampath SrisailamCampus Angels NetworkIan Angel Fund

Description

Biodimension, a Bengaluru-based life sciences startup, has raised Rs 8 crore in a funding round led by IAN Angel Fund. The proceeds will be used to enhance product development and expand their laboratory infrastructure among other goals. Founded by Manojkumar S., Ranjith Kumar Velusamy, and Pradeep Arunachalam, the company focuses on developing biofabricated human tissues as alternatives to animal testing. Collaborations with various firms will support their plans for expansion into international markets.

Company Information

Company

Biodimension

Location

Bengaluru, Karnataka, India

About

Biodimension is a Bengaluru-based life sciences startup that develops biofabricated human tissue and organoid models as alternatives to animal testing. Founded by Manojkumar S., Ranjith Kumar Velusamy, and Pradeep Arunachalam, the company provides human-relevant testing solutions for pharmaceutical, biotechnology, and cosmetic industries. Its portfolio includes innovative products like BioDEpi and Bioassay-as-a-Service. Biodimension aims to expand its research offerings and commercialization efforts both in India and international markets.

Related People

Suggested for you
2 contacts

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Biodimension's next move

Learn about Strategic plan

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.

Watching Biodimension? See every signal — funding, hires, M&A, contracts, sentiment.

Request a demoChoose your plan